World leader in developing and using expression systems for production of recombinant proteins in green plants.
Biozentrum main entrance
Green house chamber for Nicotiana benthamiana
Potted Nicotiana benthamiana plants for R&D
Laboratory for generation of magnICON® vectors
Syringe infiltration of Nicotiana benthamiana for R&D
Expression of Green Fluorescent Protein using magnICON®
Growth of Nicotiana benthamiana in trays for production
Vacuum infiltration of Nicotiana benthamiana for production
Incubation of infiltrated Nicotiana benthamiana trays
Clean room facility
Down-stream processing area
Small-scale filling of protein product
About Icon Genetics
Icon Genetics GmbH (Halle/Saale, Germany) is the world leader in developing and using expression systems for production of recombinant proteins in green plants. The company has established a new generation production platform, magnICON®, and holds a dominant patent portfolio composed of over 400 granted patents in the field of plant-based expression systems. The magnICON® platform offers an efficient transient expression technology for recombinant proteins, which addresses speed, yield, precision, expression control, flexibility, on demand production and safety; especially with respect to the regulatory requirements for production of biopharmaceuticals and proteins for diagnostic use. The technology is equally suitable for producing research samples, as well as for the large scale production of recombinant proteins of interest. Icon Genetics has built an efficient research and development pipeline for a number of biopharmaceuticals including preventive and therapeutic vaccines, as well as recombinant proteins for diagnostic use.
The Icon Genetics team has amassed extensive knowledge of successful performance in highly competitive environments. The company has built its own GMP-certified facility for R&D purposes, and a quality control department. It has also established a quality management system according to EU GMP guidelines. Icon Genetics is experienced in running FDA-approved clinical trials.
Short company profile
Address:
Icon Genetics GmbHBiozentrum
Weinbergweg 22
06120 Halle/Saale
Management directory:
Kazuyuki HirutaHiroshi Adachi
Dr. Victor Klimyuk
History:
| 1999 | Founded in USA, since 2000 in Germany |
| 2006–2011 | Subsidiary of Bayer Innovation |
| since 2012 | Subsidiary of Nomad Biosciences GmbH, Halle/Saale |
| since 2015 | Subsidiary of Denka Co., Ltd., Japan |